The Hematologic Oncology Department at Cancer Treatment Centers of America (CTCA) provides advanced medical therapies, including stem cell transplantation, for patients with blood-related diseases, including leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and multiple myeloma.
Our hematologic oncology team has expertise in treating hematologic diseases using advanced technology and a personalized approach. We use state-of-the-art diagnostic tests to develop an individualized treatment plan that's tailored to your needs.
A stem cell transplant can be used to infuse healthy stem cells into the body to stimulate new bone marrow growth, suppress the disease and reduce the possibility of a relapse. Stem cells can be found in the bone marrow, circulating blood (peripheral blood stem cells) and umbilical cord blood.
Stem cell transplantation
For patients who need a stem cell transplant, our Stem Cell Unit includes an outpatient clinic, infusion center and inpatient rooms. When you first visit the hospital, you’ll meet with the hematologic oncology team. Your doctor will review your medical records and determine if you need additional diagnostic testing, such as lab work or imaging tests.
Once you’ve completed any necessary testing, your doctor will present you with treatment options, which may include autologous or allogeneic stem cell transplants.
The hematologic oncology team will care for you throughout your treatment. You’ll stay in one of our private, inpatient rooms and receive around-the-clock monitoring and care. We'll do everything possible to see that you and your family are comfortable throughout your stay.
Helping you maintain your quality of life
Recovery from treatments like stem cell transplantation can take several months. Our hematology oncology team will work with the rest of your care team to support you throughout the entire process.
For example, your dietitian may recommend a healthy diet to nutritionally fortify your body, and your naturopathic clincian may recommend natural therapies to help reduce side effects, such as neuropathy. Your rehabilitation therapist may recommend safe levels of physical activity to help you stay active and independent.
Additionally, your pain management practitioner may use various techniques to help alleviate discomfort and control bone and neuropathic pain, while your mind-body therapist may provide counseling and relaxation techniques.
The hematologic oncology team at Midwestern
Dr. Istvan Redei serves as Director of the Stem Cell Transplant and Cell Therapy Program at CTCA at Midwestern Regional Medical Center (Midwestern).
Dr. Redei and his team, including Dr. Syed Abutalib, are dedicated to fighting hematologic malignancies with advanced and innovative medicine. They use leading treatment protocols and think "outside the box" to provide promising options and individualized care for each patient.
“We are constantly looking for the best therapy for treating each patient and his or her particular disease,” says Dr. Redei. “We monitor each patient’s treatment to see how he or she is responding to the treatment. Depending on how the patient responds, we may modify the treatment to find the one that optimizes that patient’s chances for eliminating the disease.”
Stem Cell Transplant and Cell Therapy Program accreditation
In 2014, Midwestern was recognized by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration.
FACT, an internationally recognized accrediting body for hospitals and medical institutions offering stem cell transplant, awarded Midwestern with the prestigious accreditation for meeting rigorous standards in a variety of stem cell therapies, including clinical care, donor management, cell collection, processing, storage, transportation, administration and cell release.
FACT accreditation is attained through evaluation of detailed clinical documentation and an on-site inspection to determine if an organization is in compliance with current FACT standards and the United States Food and Drug Administration's rules for Good Tissue Practice. Since 2007, FACT accreditation has been used in determining the U.S. News & World Report rankings of transplant centers for the "America's Best Hospitals" list.
Dr. Redei says, "Receiving FACT accreditation is a great honor and demonstrates to patients they are in good hands."